Altogether, our findings unveil CPLF as a data-inherent multi-omics prognostic factor and establish the CPLF/FN1/integrin axis as a key pathway mediating myofibroblast–cancer cell crosstalk in CRC progression. The gene discussed is FN1; the disease is cancer.